Will Molnupiravir be the First Oral Treatment for High-Risk Non-Hospitalized Patients with Mild-Moderate COVID-19? | Zendy

AI Assistant Blog Pricing

Open Access

Will Molnupiravir be the First Oral Treatment for High-Risk Non-Hospitalized Patients with Mild-Moderate COVID-19?

Author(s) -

Sohail Rao,

Manish Singh

Publication year - 2021

Publication title -

dhr proceedings

Language(s) - English

Resource type - Journals

ISSN - 2689-839X

DOI - 10.47488/dhrp.v1is4.29

Subject(s) - covid-19 , medicine , virology , outbreak , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.